Coumarin derivatives, process for their preparation, their use and thiazolyl acetic acid derivatives as intermediates

Assignee: Bayer AG

•

Filing: 1992-07-16

•

Granted: 1994-04-05

•

Expires: 2012-07-16

📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Coumarin deviatives of the formula <IMAGE> (I) in which R1 denotes cyano, R2 represents phenyl or thiazolyl bonded in the 2-, 4-, or 5-position, R3 denotes hydrogen, C1-C4-alkyl or C1-C4 -alkoxycarbonyl-C1-C4-alkyl and R4 represents hydrogen, C1-C4-alkyl or phenylsulphonyl, where C1-C4-alkyl can be substituted by hydroxyl, amino, carboxyl or C1-C4-alkoxy-carbonyl and phenyl can be monosubstituted or disubstituted by chlorine, bromine or C1-C4-alkyl, where furthermore R3 and R4, together with the N atom which they substitute, can denote a morpholine ring, a piperazine ring or a triazole ring which can carry one or two substituents from the group comprising methyl, ethyl and phenyl, and where furthermore one of the radicals R2, R3 and R4 denotes or carries a primary or secondary amino group, the hydroxyl group, the carboxyl group or the C1-C4-alkoxy-carbonyl group or can be converted into such a group by hydrolysis or hydrogenation, are suitable for dyeing biologically active compounds.

Inventors

👤 Eberhard Kuckert
👤 Gunther Beck
👤 Florin Seng
👤 Antonius Lobberding

Bibliographic Details

Application Number —

Jurisdiction US

Data Source google_patents

Last Synchronized 2026-10-30 20:23

CPC Classifications

C; C07; C07D; C07D277/00; C07D277/02; C07D277/20; C07D277/32; C07D277/56; C07D311/00; C07D311/02; C07D311/04; C07D311/06; C07D311/08; C07D311/16; C07D417/00; C07D417/02; C07D417/04; G; G01; G01N; G01N21/00; G01N21/62; G01N21/63; G01N21/64; G01N21/6428; G01N33/00; G01N33/48; G01N33/50; G01N33/53; G01N33/536; G01N33/542; G01N33/543; G01N33/54366; G01N33/54373; G01N33/544; G01N33/545; G01N33/551; G01N33/552; G01N33/553; G01N33/58; G01N33/582

Claims Analysis

Total Claims: 4

Claim 1

Independent Claim 213 words

A coumarin derivative of the formula ##STR37## in which R 1 denotes cyano, R 2 represents phenyl or thiazolyl bonded in that 2-, 4- or 5-position, where phenyl is substituted by nitro, cyano, amino, --CH--C 1 -C 4 -alkyl, --C 1 -C 4 -alkyl-NH 2 , --C 1 -C 4 -alkyl-NH--C 1 -C 4 -alkyl, carboxyl, C 1 -C 4 -alkoxycarbonyl, C 1 -C 4 -alkyl-carbonyloxy, hydroxyl, C 1 -C 4 -alkylamino-carbonyl or C 1 -C 4 -alkylcarbonylamino and can additionally be substituted by C 1 1∝C 4 -alkyl, fluorine, chlorine, or bromine, and where thiazolyl is monosubstituted or disubstituted by chlorine, cyano, where, in the case of disubstitution, the two substituents may be different and where the 4- and 5-position can together carry a fused benzene ring which can be substituted by carboxyl, amino or hydroxyl, R 3 denotes C 1 -C 4 -alkyl or C 1 -C 4 -alkoxycarbonyl-C 1 -C 4 -alkyl and R 4 represents C 1 -C 4 -alkyl which is substituted by hydroxyl, amino, carboxyl or C 1 -C 4 -alkoxy-carbonyl and provided that one of the radicals R 2 , R 3 and R 4 carries a primary or secondary amino group, the hydroxyl group, the carboxyl group or the C 1 -C 4 -alkoxy-carbonyl group.

Claim 2

Dependent Claim 213 words

Claim 3

Dependent Claim 191 words

The coumarin derivative of claim 1 of the formula ##STR38## in which R 1 denotes cyano, R 12 represents phenyl or thiazolyl bonded in the 2-, 4or 5-position, where phenyl can be substituted by carboxyl, C 1 -C 4 -alkyl-carbonyloxy, amino, --NH-C 1 -C 4 -alkyl, --C 1 C 4 -alkyl-NH 2 , C 1 C 4 -alkyl, cyano, fluorine, chlorine or bromine and where thiazolyl can be substituted by chlorine, cyano or a benzene ring fused in the 4- and 5-position, which in turn can carry carboxyl or amino, R 13 denotes hydrogen, methyl or ethyl and R 14 represents --C 1 --C 4 -alkyl-OH, --C 1 --alkyl-NH 2 or C 1 -C 4 -alkyl-COOH, where furthermore R 13 and R 14 , together with the N atom which they substitute, can denote a morpholine ring, a piperazine ring or a triazolyl ring which can be substituted by methyl, phenyl or methyl and phenyl, and where furthermore one of the radicals R 12 , R 13 and R 14 carries a primary or secondary amino group, the hydroxyl group, the carboxyl group or a C 1 -C 2 -alkoxy-carbonyl group.

Claim 4

Dependent Claim 117 words

The coumarin derivative of claim 2 of the formula ##STR39## in which R 1 , R 13 and R 14 assume the scope of meaning mentioned in claim 2 and R 22 represents phenyl or thiazolyl bonded in the 2-position, where phenyl can be substituted by paracarboxyl, para-amino, para-NH≧C 1 -C 4 -alkyl, para-CH 2 -NH 2 , cyano, methyl or ethyl and where thiazolyl can be substituted by chlorine, cyano or a benzene ring fused in the 4- and 5-position which in turn can carry carboxyl or amino, where furthermore one of the radicals R 13 , R 14 and R 22 carries a primary or secondary amino group, the hydroxyl group or the carboxyl group.

References Cited (Backward Citations)

DE154402C Cited

DE2710285A1 Cited

DE2712408A1 Cited

US4404389A Cited

US4547579A Cited

EP0025136A1 Cited

US4764622A Cited

EP0032670A1 Cited

EP0056577A1 Cited

EP0101897A1 Cited

DE3609804A1 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage	Window Opens	Payment Deadline	Surcharge Period Until	Estimated Fee	Status
3.5 Years (Year 4)	1997-04-04	1997-10-04	1998-04-05	$2000.00	Window Closed / Lapsed
7.5 Years (Year 8)	2001-04-04	2001-10-04	2002-04-05	$3760.00	Window Closed / Lapsed
11.5 Years (Year 12)	2005-04-04	2005-10-04	2006-04-05	$7700.00	Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag

Select Category

Notes (Optional)